Fig. 6

The association between TIME and the propionate-related risk score in TNBC. (A and B) The difference in immune cell infiltration between the high-risk group and the low-risk group of training (A) and validation (B) sets. (C and D) Distinguishing of enrichment of immune-associated signatures between different risk groups of training (C) and validation (D) sets. *p < 0.05; **p < 0.01; ***p < 0.001 (Wilcoxon rank sum test).